Contact
Please use this form to send email to PR contact of this press release:
Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment
TO:
Please use this form to send email to PR contact of this press release:
Valneva Commences Manufacturing of its Inactivated, Adjuvanted COVID-19 Vaccine, Completes Phase 1/2 Study Recruitment
TO: